Overheads are too high and having a raising so quickly after listing is not a good sign. I think they need to re look at their model, as not really working.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025